DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

One Mobikwik Systems Limited — Analyst/Investor Meet Para A-XBRL

NSE 25 Aug·25 Aug 2026, 12:07 pm

ONE Mobikwik Systems

One MobiKwik Systems Limited has announced its participation in an analyst or institutional investor meeting. The company has informed the stock exchanges about this event to ensure transparency regarding its communication with the investment community.

This disclosure is a routine corporate governance practice. It signals that the company is open to engaging with market participants, potentially to discuss its business performance, future strategy, or financial outlook. For investors, this indicates active management and a willingness to provide clarity on the company's direction.

Investors should watch for any specific details or guidance shared during this interaction. While the announcement itself is neutral, the insights provided by the management during the meet could offer valuable context for evaluating the stock's future prospects.